DE60231651D1 - Proteinreinigungsverfahren - Google Patents

Proteinreinigungsverfahren

Info

Publication number
DE60231651D1
DE60231651D1 DE60231651T DE60231651T DE60231651D1 DE 60231651 D1 DE60231651 D1 DE 60231651D1 DE 60231651 T DE60231651 T DE 60231651T DE 60231651 T DE60231651 T DE 60231651T DE 60231651 D1 DE60231651 D1 DE 60231651D1
Authority
DE
Germany
Prior art keywords
protein
cleaning process
bind
proteins
hydroxyapatite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231651T
Other languages
English (en)
Inventor
Ganesh Vedantham
Clayton A Brooks
Joanne M Reeder
Andrew M Goetze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27407561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60231651(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DE60231651D1 publication Critical patent/DE60231651D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60231651T 2001-12-21 2002-12-20 Proteinreinigungsverfahren Expired - Lifetime DE60231651D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34336301P 2001-12-21 2001-12-21
US34718902P 2002-01-08 2002-01-08
US36427202P 2002-03-12 2002-03-12
PCT/US2002/041159 WO2003059935A2 (en) 2001-12-21 2002-12-20 Methods for purifying protein

Publications (1)

Publication Number Publication Date
DE60231651D1 true DE60231651D1 (de) 2009-04-30

Family

ID=27407561

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231651T Expired - Lifetime DE60231651D1 (de) 2001-12-21 2002-12-20 Proteinreinigungsverfahren

Country Status (11)

Country Link
US (2) US7122641B2 (de)
EP (1) EP1463942B2 (de)
JP (1) JP4363986B2 (de)
AT (1) ATE425989T1 (de)
AU (1) AU2002359816B2 (de)
CA (1) CA2469815C (de)
DE (1) DE60231651D1 (de)
ES (1) ES2322945T5 (de)
MX (1) MXPA04006053A (de)
PL (1) PL374311A1 (de)
WO (1) WO2003059935A2 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329388B2 (en) 1999-11-08 2008-02-12 Princeton Biochemicals, Inc. Electrophoresis apparatus having staggered passage configuration
US6406604B1 (en) 1999-11-08 2002-06-18 Norberto A. Guzman Multi-dimensional electrophoresis apparatus
WO2003059935A2 (en) * 2001-12-21 2003-07-24 Immunex Corporation Methods for purifying protein
CN100522989C (zh) 2002-09-11 2009-08-05 中外制药株式会社 纯化蛋白质的方法
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
CA2536918A1 (en) 2003-08-26 2005-03-03 Leland Shapiro Compositions of, and methods for, alpha-1 antitrypsin fc fusion molecules
DK1678208T3 (da) * 2003-10-27 2013-07-08 Wyeth Llc Fjernelse af aggregater med høj molekylvægt under anvendelse af hydroxyapatitchromatografi
US8007725B2 (en) 2003-11-07 2011-08-30 Princeton Biochemicals, Inc. Electrophoresis apparatus having valve system
EP1706735B1 (de) 2003-11-07 2017-01-04 Princeton Biochemicals, Inc. Mehrdimensionale elektrophoresevorrichtung
US20080261249A1 (en) * 2004-01-13 2008-10-23 Genentech, Inc Detecting and Quantifying Host Cell Proteins in Recombinant Protein Products
JP4872327B2 (ja) * 2004-11-26 2012-02-08 東レ株式会社 改質されたインターロイキン−１１とその製造方法
ES2797480T3 (es) * 2005-03-11 2020-12-02 Wyeth Llc Un procedimiento de cromatografía de reparto débil
US20060240564A1 (en) * 2005-04-20 2006-10-26 Chia-Hui Shieh pH gradient ion exchange LC-MS and mass compatible buffers
BRPI0611901A2 (pt) 2005-06-14 2012-08-28 Amgen, Inc composição, liofilizado, kit, e, processo para preparar uma composição
US7375188B2 (en) 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof
EP1816201A1 (de) 2006-02-06 2007-08-08 CSL Behring GmbH Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
KR20150006085A (ko) 2006-04-05 2015-01-15 애브비 바이오테크놀로지 리미티드 항체 정제
EP1867660A1 (de) 2006-06-14 2007-12-19 CSL Behring GmbH Fusionsprotein welches proteolytisch geschnitten werden kann und einen Faktor der Blutgerinnungskaskade enthält
WO2007144173A1 (en) 2006-06-14 2007-12-21 Csl Behring Gmbh Proteolytically cleavable fusion protein comprising a blood coagulation factor
US7939632B2 (en) 2006-06-14 2011-05-10 Csl Behring Gmbh Proteolytically cleavable fusion proteins with high molar specific activity
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法
JP2010501622A (ja) * 2006-08-28 2010-01-21 アレス トレーディング ソシエテ アノニム Ｆｃ−融合タンパク質の精製法
ZA200900836B (en) * 2006-08-28 2010-05-26 Ares Trading Sa Process for the purification of FC-fusion proteins
MX2009002014A (es) 2006-08-28 2009-03-09 Ares Trading Sa Proceso para la purificacion de proteinas que contienen fc.
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
SG10201510384UA (en) 2006-09-13 2016-01-28 Abbvie Inc Cell culture improvements
US7488807B2 (en) * 2006-11-22 2009-02-10 3M Innovative Properties Company Antibody with protein A selectivity
US20100047252A1 (en) * 2006-11-22 2010-02-25 3M Innovative Properties Company Antibody with protein a selectivity
CA2673459C (en) 2006-12-22 2016-09-13 Stefan Schulte Modified coagulation factors with prolonged in vivo half-life
WO2009092014A1 (en) * 2008-01-18 2009-07-23 Gagnon Peter S Enhanced purification of antibodies and antibody fragments by apatite chromatography
US20100058173A1 (en) * 2008-08-28 2010-03-04 Kabushiki Kaisha Toshiba Display processing apparatus, display processing method, and computer program product
CA2736141C (en) * 2008-09-23 2018-03-20 F. Hoffmann-La Roche Ag Purification of erythropoietin
WO2010048192A2 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
MX2011004200A (es) * 2008-10-20 2011-05-24 Abbott Lab Aislamento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a.
WO2010051360A1 (en) * 2008-10-31 2010-05-06 Wyeth Llc Purification of acidic proteins using ceramic hydroxyapatite chromatography
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
IN2012DN05169A (de) * 2009-12-02 2015-10-23 Acceleron Pharma Inc
US8951807B2 (en) 2010-01-15 2015-02-10 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
EP2571892A2 (de) * 2010-05-18 2013-03-27 AbbVie Inc. Vorrichtung und verfahren der reinigung von proteinen
US8895707B2 (en) 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
JP5881744B2 (ja) * 2011-02-02 2016-03-09 バイオ−ラッド ラボラトリーズ インコーポレーティッド アルカリ溶液でのアパタイトの表面中和方法
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US8911992B2 (en) * 2011-04-28 2014-12-16 Bio-Rad Laboratories, Inc. DNA removal in target molecule purification
EP2718328A4 (de) 2011-06-08 2014-12-24 Acceleron Pharma Inc Zusammensetzungen und verfahren zur erhöhung der halbwertszeit von serum
CA2839917A1 (en) 2011-06-24 2012-12-27 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
KR20140043934A (ko) * 2011-07-08 2014-04-11 머크 샤프 앤드 돔 코포레이션 Ｆｃ-융합 단백질의 정제 방법
JP2015504675A (ja) 2012-01-10 2015-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ アルファ−１アンチトリプシン融合分子の組成物、方法、及び使用
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
WO2013180933A1 (en) 2012-05-30 2013-12-05 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
BR112015004467A2 (pt) 2012-09-02 2017-03-21 Abbvie Inc método para controlar a heterogeneidade de proteínas
WO2014042923A1 (en) 2012-09-13 2014-03-20 Indiana University Research & Technology Corporation Compositions and systems for conferring disease resistance in plants and methods of use thereof
AU2013381687A1 (en) 2013-03-12 2015-09-24 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
JP6457479B2 (ja) * 2013-03-14 2019-01-23 アムジエン・インコーポレーテツド 漏出したアフィニティ精製リガンドの除去
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US10099157B2 (en) 2014-06-23 2018-10-16 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
WO2015200282A1 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite pretreatment
GB2528301A (en) * 2014-07-17 2016-01-20 Univ Newcastle Biomolecule separation using apatite
WO2018063980A1 (en) * 2016-09-29 2018-04-05 Bio-Rad Laboratories, Inc. Agarose-filled ceramic apatite
CN114917185B (zh) 2016-10-21 2023-11-14 美国安进公司 药物配制品及其制备方法
EP3887386A4 (de) * 2018-11-26 2022-11-30 North Carolina State University Peptidliganden zur einfangen von wirtszellproteinen
EP4142792A1 (de) * 2020-05-01 2023-03-08 Kashiv Biosciences, LLC Verbessertes verfahren zur reinigung von protein
KR20230124578A (ko) 2020-12-22 2023-08-25 암젠 인크 세포 배양 방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745183A (en) * 1984-02-21 1988-05-17 Bio-Rad Laboratories, Inc. Use of hydroxylapatite for the analysis and preparation of purified monoclonal antibodies
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
JPH0774231B2 (ja) 1986-12-11 1995-08-09 東燃株式会社 抗体の分離方法
US4933286A (en) * 1987-03-30 1990-06-12 Plant Cell Research Institute, Inc. Purification of apase-11 and retrieval of the nematode resistance gene
US5115101A (en) * 1988-06-08 1992-05-19 Miles Inc. Removal of protein A from antibody preparations
JPH022937A (ja) 1988-06-17 1990-01-08 Toray Ind Inc 酵素標識抗体の分離精製方法
JPH03139292A (ja) 1989-05-22 1991-06-13 Toray Ind Inc ヒトインタ―ロイキン―６に対するモノクロ―ナル抗体
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
JPH03291300A (ja) 1989-12-28 1991-12-20 Mitsui Toatsu Chem Inc ポリクローナル抗体の分離方法
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
JPH04368399A (ja) 1991-06-12 1992-12-21 Toagosei Chem Ind Co Ltd 抗体の分離方法
JP2961986B2 (ja) 1991-08-22 1999-10-12 東亞合成株式会社 ポリクローナル抗体の分離精製方法
DE4205938A1 (de) * 1992-02-27 1993-09-02 Medac Klinische Spezialpraep Immunotoxine
JP3178080B2 (ja) 1992-04-28 2001-06-18 チッソ株式会社 抗体の分離精製方法
US5278284A (en) * 1992-05-14 1994-01-11 Miller Brewing Company Protein purification method
US6099830A (en) * 1994-08-09 2000-08-08 Zymogenetics, Inc. Methods for stimulating erythropoiesis using hematopoietic proteins
US5641655A (en) * 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
JPH08188599A (ja) 1995-01-09 1996-07-23 Toagosei Co Ltd ＩｇＹ抗体の分離精製方法
US5744587A (en) * 1995-06-07 1998-04-28 Zymogenetics, Inc. Method for purifying thrombopoietin
SI0950067T1 (sl) * 1996-11-27 2007-12-31 Genentech Inc Afinitetno čiščenje polipeptida na proteinskemA matriksu
PT998486E (pt) * 1997-06-13 2007-08-21 Genentech Inc ''recuperação de proteínas por cromatografia seguida de filtração numa camada carregada''
WO2003059935A2 (en) * 2001-12-21 2003-07-24 Immunex Corporation Methods for purifying protein
AU2003207496A1 (en) * 2002-01-10 2003-07-30 Syngenta Participations Ag Phytophthora infestans cdc 14 phosphatase gene, protein and methods of use

Also Published As

Publication number Publication date
US7476722B2 (en) 2009-01-13
ES2322945T5 (es) 2012-10-17
EP1463942A2 (de) 2004-10-06
US20070010661A1 (en) 2007-01-11
US20030166869A1 (en) 2003-09-04
WO2003059935A2 (en) 2003-07-24
PL374311A1 (en) 2005-10-03
EP1463942B2 (de) 2012-06-20
AU2002359816A1 (en) 2003-07-30
JP2005538686A (ja) 2005-12-22
WO2003059935A3 (en) 2003-10-16
ATE425989T1 (de) 2009-04-15
MXPA04006053A (es) 2005-03-31
ES2322945T3 (es) 2009-07-02
JP4363986B2 (ja) 2009-11-11
AU2002359816B2 (en) 2006-07-13
CA2469815A1 (en) 2003-07-24
CA2469815C (en) 2011-05-03
EP1463942B1 (de) 2009-03-18
EP1463942A4 (de) 2005-01-19
US7122641B2 (en) 2006-10-17

Similar Documents

Publication Publication Date Title
DE60231651D1 (de) Proteinreinigungsverfahren
ES2177632T3 (es) Purificacion de anticuerpos.
KR950700779A (ko) 단백질의 정제방법(Protein purification)
ATE363491T1 (de) Reinigung von antikörpern durch protein a und ionenaustauschromatographie
CY1119024T1 (el) Καθαρισμος πρωτεϊνης
PT1308455E (pt) Composicao compreendendo anticorpos anti-her2
DK0458841T3 (da) Fremgangsmåde til anvendelse og fremstilling af peptider
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
ATE361930T1 (de) Proteinreinigung mittels chromatographie und darauffolgende filtration auf beladener schicht
DE69739187D1 (de) Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus
DK1115745T3 (da) Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
ATE250966T1 (de) Adsoptionschromatographie
ATE302793T1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
GB9800378D0 (en) Proteome analysis
ATE246204T1 (de) Verfahren zur trennung und/oder isolierung von plasmaproteinen mit annularer chromatographie
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
ES2135480T3 (es) Nueva molecula de celula endotelial que media la union de linfocitos en el hombre.
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung

Legal Events

Date Code Title Description
8363 Opposition against the patent